Innovent and Eli Lilly sign a China commercialization deal for Verzenios, expanding patient access w

Pfizer and Verizon Communications are extremely high-yielding dividend stocks that trade at low valu

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified wa

Pfizer (PFE) closed at $24.08 in the latest trading session, marking a -1.19% move from the prior da

Volatility can lower the cost of entry into businesses that throw off real cash, even as investors r

I keep buying Pfizer (NYSE:PFE | PFE Price Prediction) every time my brokerage cash builds up, and I

Few large-cap dividends generate as much skepticism as Pfizer (NYSE:PFE | PFE Price Prediction).

It could prove to be a case of better later than never for the healthcare giant.

A bipartisan group of United States lawmakers has opened national security investigations into wheth

This relationship between inflation and value stocks' outperformance is often overlooked. Many inves

AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.

At 66 with $1.3 million, the math is straightforward. A 5% blended yield throws off roughly $65,000

Pfizer Canada ULC announced today that Health Canada has, under priority review and Project Orbis in

Why settle for puny yields when you can buy these monster dividend stocks?

Pfizer's GLP-1 ​drug Ecnoglutide ‌and Innovent Biologics' ​mazdutide injection ​have passed a ⁠preli

One of Pfizer's promising oncology candidates recently failed a phase 3 study. The drugmaker is also

Pfizer is one of the world's largest drug companies. It has a long history of navigating the industr

Pfizer's high yield is the result of the stock's lingering underperformance, reflecting one serious

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

When Pfizer was coming out of the COVID-induced growth phase in early 2024, I turned bullish alongsi

KeyBanc downgraded Nike, citing slower-than-expected progress in its turnaround strategy and mountin

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the

AbbVie is aggressively expanding its pipeline to offset the impact of biosimilar competition for its

Merck wins EU approval for Keytruda plus Padcev in patients with resectable muscle-invasive bladder

The FDA approves Pfizer's Ibrance regimen for HR+, HER2+ metastatic breast cancer maintenance af

Pfizer shares are trading flat in Wednesday's premarket as traders weigh mixed Phase 3 trial hea

Pfizer's sigvotatug vedotin missed its Phase 3 OS goal in NSCLC but showed encouraging results i

Pfizer Inc. (NYSE:PFE) today announced topline results from the Phase 3 SigVie-002 study (previously

Pfizer shares are trading lower by about half a percent on Monday as investors digest a leadership t

As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and s

The Nasdaq 100 has tripled since 2020, but 10 mega-caps still trade below pre-Covid levels. Who'

https://www.sec.gov/ix?doc=/Archives/edgar/data/78003/000007800326000087/pfe-20260618.htm

Pfizer shares are slipping Thursday after it announced that Chief Financial Officer Dave Denton will

FDA Expands Merck CAPVAXIVE Use To At-Risk Children And Adolescents Aged 2-17 Following Positive Pha

Pfizer Inc. (NYSE:PFE) today announced that Dave Denton, Chief Financial Officer, will step down fro

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a commercial stage biotechnology company focused on hemat

https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-

Some investors want no part of the SpaceX IPO, saying the company is being valued at nearly 100 time

RBC Capital analyst Trung Huynh upgrades Pfizer (NYSE:PFE) from Underperform to Sector Perform an

AI cancer detection tool seeks FDA approval as experts weigh benefits and risks of earlier diagnosis

Pfizer reports Phase 2b obesity drug data showing 15.9% weight loss as FDA expands HYMPAVZI use for

Pfizer Inc. (NYSE:PFE)today announced that the U.S. Food and Drug Administration (FDA) has approved

Results from multiple Phase 2b dose finding studies for berobenatide (PF'3944) highlight a poten

Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distribut

Chai Discovery, the company engineering AI models to discover new molecules, today announced a licen

In turbulent markets, investors turn to dividend-yielding stocks. Here are analyst ratings for high-

Patients had a 55% likelihood of remaining alive without disease progression at seven years, and med

Pfizer Inc. (NYSE:PFE) and Innovent Biologics, Inc. (01801.HK), today announced the companies have e

Pfizer and Innovent Biologics sign a $10.5 billion cancer drug deal to develop 12 oncology programs